Evolution of the Concept of Sepsis
Abstract
:1. Introduction
2. Evolution in Concepts: Impact on Definitions
2.1. The Sepsis Syndrome
2.2. ‘First’ Sepsis Definitions Conference and SIRS
2.3. ‘Second’ Sepsis Definitions Conference
2.4. Third Sepsis Definitions Conference
3. Conclusions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Geroulanos, S.; Douka, E.T. Historical perspective of the word “sepsis”. Intensive Care Med. 2006, 32, 2077. [Google Scholar] [CrossRef]
- Bone, R.C.; Fisher, C.J., Jr.; Clemmer, T.P.; Slotman, G.J.; Metz, C.A.; Balk, R.A. Sepsis syndrome: A valid clinical entity. Methylprednisolone Severe Sepsis Study Group. Crit. Care Med. 1989, 17, 389–393. [Google Scholar] [CrossRef] [PubMed]
- Fisher, C.J.; Dhainaut, J.F.; Opal, S.M.; Pribble, J.P.; Balk, R.A.; Slotman, G.J.; Iberti, T.J.; Rackow, E.C.; Shapiro, M.J.; Greenman, R.L.; et al. Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. JAMA 1994, 271, 1836–1843. [Google Scholar] [PubMed]
- Abraham, E.; Wunderink, R.; Silverman, H.; Perl, T.M.; Nasraway, S.; Levy, H.; Bone, R.; Wenzel, R.P.; Balk, R.; Allred, R.; et al. Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group. JAMA 1995, 273, 934–941. [Google Scholar] [CrossRef] [PubMed]
- Bone, R.C.; Balk, R.A.; Cerra, F.B.; Dellinger, R.P.; Fein, A.M.; Knaus, W.A.; Schein, R.M.; Sibbald, W.J. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992, 101, 1644–1655. [Google Scholar] [CrossRef] [Green Version]
- Vincent, J.L. Dear SIRS, I’m sorry to say that I don’t like you. Crit. Care Med. 1997, 25, 372–374. [Google Scholar] [CrossRef] [PubMed]
- Levy, M.M.; Fink, M.P.; Marshall, J.C.; Abraham, E.; Angus, D.; Cook, D.; Cohen, J.; Opal, S.M.; Vincent, J.L.; Ramsay, G. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit. Care Med. 2003, 31, 1250–1256. [Google Scholar] [CrossRef] [PubMed]
- Rhee, C.; Gohil, S.; Klompas, M. Regulatory mandates for sepsis care—Reasons for caution. N. Engl. J. Med. 2014, 370, 1673–1676. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Vincent, J.L.; Lefrant, J.Y.; Kotfis, K.; Nanchal, R.; Martin-Loeches, I.; Wittebole, X.; Sakka, S.G.; Pickkers, P.; Moreno, R.; Sakr, Y. Comparison of European ICU patients in 2012 (ICON) versus 2002 (SOAP). Intensive Care Med. 2018, 44, 337–344. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kadri, S.S.; Rhee, C.; Strich, J.R.; Morales, M.K.; Hohmann, S.; Menchaca, J.; Suffredini, A.F.; Danner, R.L.; Klompas, M. Estimating ten-year trends in septic shock incidence and mortality in United States academic medical centers using clinical data. Chest 2017, 151, 278–285. [Google Scholar] [CrossRef] [PubMed]
- Vincent, J.L.; Opal, S.; Marshall, J.C.; Tracey, K.J. Sepsis definitions: Time for change. Lancet 2013, 381, 774–775. [Google Scholar] [CrossRef] [Green Version]
- Singer, M.; Deutschman, C.S.; Seymour, C.W.; Shankar-Hari, M.; Annane, D.; Bauer, M.; Bellomo, R.; Bernard, G.R.; Chiche, J.D.; Coopersmith, C.M.; et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016, 315, 801–810. [Google Scholar] [CrossRef] [PubMed]
- Vincent, J.L.; De Backer, D. Circulatory shock. N. Engl. J. Med. 2013, 369, 1726–1734. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Vincent, J.L.; Moreno, R.; Takala, J.; Willatts, S.; de Mendonça, A.; Bruining, H.; Reinhart, C.K.; Suter, P.M.; Thijs, L.G. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med. 1996, 22, 707–710. [Google Scholar] [CrossRef]
- Singer, M.; Inada-Kim, M.; Shankar-Hari, M. Sepsis hysteria: Excess hype and unrealistic expectations. Lancet 2019, 394, 1513–1514. [Google Scholar] [CrossRef] [Green Version]
- Schuurman, A.R.; Reijnders, T.D.Y.; Kullberg, R.F.J.; Butler, J.M.; van der Poll, T.; Wiersinga, W.J. Sepsis: Deriving biological meaning and clinical applications from high-dimensional data. Intensive Care Med. Exp. 2021, 9, 27. [Google Scholar] [CrossRef]
Construct | Pathophysiology | Clinical Features |
---|---|---|
Sepsis | Dysregulated host response to infection | Infection + organ dysfunction |
ARDS | Pulmonary edema due to leaky capillaries | Severe hypoxemia Bilateral lung infiltrates No evidence of hemodynamic type lung edema |
Coma | Altered brain function | Altered consciousness |
Dementia | Damage, degeneration, or loss of brain cells and/or their connections | Confusion Loss of memory Abnormal behavior |
Condition | Definition | Criteria |
---|---|---|
Myocardial infarction | Thrombotic event in a coronary artery | Abnormal EKG, elevated blood troponin levels |
Pneumonia | Pulmonary infection | Fever, abnormal WBC count, raised CRP, abnormal chest X-ray/CT scan |
Category | Sign/Symptom |
---|---|
General | Rigor–fever (sometimes hypothermia) Tachypnea/respiratory alkalosis Positive fluid balance–edema |
Hematologic/inflammatory reaction | Leukocytosis (sometimes leukopenia)–increased immature forms Increased CRP, IL-6, procalcitonin concentrations |
Hemodynamic alterations | Arterial hypotension Tachycardia Increased cardiac output/low SVR/high SvO2 Altered skin perfusion (cold, mottled extremities, petechiae, etc.) Decreased urine output Hyperlactatemia–increased base deficit |
Signs of organ dysfunction | Hypoxemia (ALI/ARDS) Altered mental status Altered renal function Hyperglycemia Thrombocytopenia–DIC Intolerance to feeding (altered gut motility) Altered liver tests (hyperbilirubinemia) |
Score | 0 | 1 | 2 | 3 | 4 |
---|---|---|---|---|---|
Respiratory | |||||
PaO2/FiO2, mmHg | ≥400 | <400 | <300 | <200 | <100 |
--------with respiratory support------- | |||||
Coagulation | |||||
Platelets × 103/mm3 | ≥150 | <150 | <100 | <50 | <20 |
Liver | |||||
Bilirubin, mg/dL (μmol/L) | <1.2 (<20) | 1.2–1.9 (20–32) | 2.0–5.9 (33–101) | 6.0–11.9 (102–204) | >12.0 (>204) |
Cardiovascular | |||||
Hypotension | No hypotension | MAP < 70 mmHg | dopamine ≤ 5 or dobutamine (any dose) * | dopamine > 5 or epinephrine ≤ 0.1 or norepinephrine ≤ 0.1 * | dopamine > 15 or epinephrine > 0.1 or norepinephrine > 0.1 * |
Central nervous system | |||||
Glasgow Coma Scale | 15 | 13–14 | 10–12 | 6–9 | <6 |
Renal | |||||
Creatinine, mg/dL (μmol/L) | <1.2 (<110) | 1.2–1.9 (110–170) | 2.0–3.4 (171–299) | 3.5–4.9 (300–440) | >5.0 (>440) |
OR urine output | <500 mL/d | <200 mL/d |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Vincent, J.-L. Evolution of the Concept of Sepsis. Antibiotics 2022, 11, 1581. https://doi.org/10.3390/antibiotics11111581
Vincent J-L. Evolution of the Concept of Sepsis. Antibiotics. 2022; 11(11):1581. https://doi.org/10.3390/antibiotics11111581
Chicago/Turabian StyleVincent, Jean-Louis. 2022. "Evolution of the Concept of Sepsis" Antibiotics 11, no. 11: 1581. https://doi.org/10.3390/antibiotics11111581
APA StyleVincent, J.-L. (2022). Evolution of the Concept of Sepsis. Antibiotics, 11(11), 1581. https://doi.org/10.3390/antibiotics11111581